Surromed, Inc.

Menlo Park, CA 94025

SBIR Award Summary

Total Number of Awards 10
Total Value of Awards $1.63MM
First Award Date 03/01/01
Most Recent Award Date 09/21/04

Key Personnel

Last Name Name Awards Contact
Becker Christopher Becker 2
Schulman Howard Schulman 3
Cromer Remy G Cromer 1
Kantor Aaron B. Kantor 3
Freeman Richard G Freeman 1

10 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-52
Budget: 09/21/04 - 01/31/05

DESCRIPTION (provided by applicant): Biomarkers are needed in Multiple Sclerosis (MS) for the early and accurate diagnosis of the disease, monitoring of disease progression and evaluating therapeutic intervention. SurroMed is applying technologies for comprehensive phenotyping, including advanced proteomics and metabolomics, to detect, identify ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-52
Budget: 08/01/04 - 07/31/05

DESCRIPTION (provided by applicant): Phenotypic and genetic markers are urgently needed in autoimmune diseases for early and accurate diagnosis and monitoring disease progression and therapeutic intervention. We are proposing comprehensive phenotypic analysis for the identification of biological markers and genetic mapping of these quantifiable ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-25
Budget: 05/01/04 - 04/30/05

DESCRIPTION (provided by applicant): Two of the priority research areas identified by the NIH Bioengineering Nanotechnology Initiative are Nanoimaging and Molecular and Cellular Sensing/Signaling. This proposal presents SERS nanotags (SERS = Surface Enhanced Raman Scattering), a new detection technology, which will enable the rapid and quantit...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-01-105
Budget: 05/01/04 - 04/30/05

DESCRIPTION (provided by applicant): Protein kinases are important regulators of intracellular signal-transduction pathways mediating cellular growth and development. The defining feature of malignant neoplasms is their deregulated cell growth. Understanding the underlying phosphoproteome in normal and tumor tissue together with an understand...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/29/03 - 08/31/04

DESCRIPTION (provided by applicant): There is need to develop an agent that can be used to prevent or treat arterial or venous thrombosis without increasing hemorrhage. The human placental anticoagulant protein annexin V inhibits coagulation by binding to phosphatidylserine on the outer surface of activated platelets in which phospholipid asymme...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-52
Budget: 08/01/03 - 07/31/04

DESCRIPTION (provided by applicant): Phenotypic and genetic markers are urgently needed in autoimmune diseases for early and accurate diagnosis and monitoring disease progression and therapeutic intervention. We are proposing comprehensive phenotypic analysis for the identification of biological markers and genetic mapping of these quantifiable ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/03 - 06/30/05

DESCRIPTION (provided by applicant): Biomarkers are urgently needed for the early and accurate diagnosis of Alzheimer's disease (AD). SurroMed, Inc. is using high throughput, metabolomic and proteomic approaches to differentially quantify hundreds to thousands of molecules in human cerebrospinal fluid (CSF), serum, and urine to identify biomark...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/02 - 09/30/03

DESCRIPTION (provided by applicant): Biomarkers are urgently needed for the early and accurate diagnosis of Alzheimer's disease (AD). SurroMed is using a high throughput, multiplexed proteomics approach to detect, identify and quantify a large number of putative biomarkers in animal models and human cerebrospinal fluid (CSF) specimens. Aim I pr...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-01-105
Budget: 04/03/02 - 03/31/03

Innovative regents have historically driven breakthroughs in biomedical science; we propose to develop proteomic reagents and technologies to power comprehensive biomarker and target discover for detection, prognosis, patient stratification, and therapeutics in cancer. The technical hurdles in proteomics are sample preparation (separation) and ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/01 - 08/31/01

DESCRIPTION: Phenotyping involves quantifying the vast array of molecular components that make up complex organisms. This proposal concerns nanobarcodes, a potentially revolutionary new technology platform for phenotyping. Nanobarcodes are free-standing, cylindrically-shaped colloidal metal nanopar...

Load More